Malaria remains one of the most persistent and deadly public health challenges of the modern era, with its burden falling disproportionately on Africa — and acutely on Ethiopia.
According to the World Health Organization, an estimated 282 million malaria cases were recorded globally in 2024, alongside roughly 610,000 deaths. Nearly 90 percent of both infections and fatalities occurred in Africa, underscoring the continent’s unequal share of the disease. Children under five remain the most vulnerable: more than 80 percent of malaria cases in this age group occur in Africa, and they account for approximately three-quarters of all malaria-related deaths.
Ethiopia is among the countries most affected. Data from the Institute for Health Metrics and Evaluation indicate that malaria cases in the country rose from 3.3 million in 2022 to 4.1 million in 2023, with roughly 80 percent of cases concentrated among rural, farming populations. The nation ranks among the top five globally in malaria-related mortality, contributing approximately 3.6 percent of total deaths.
The persistence of malaria in Ethiopia is not new. Historical records suggest that the disease has been among the leading causes of illness in the country for well over a century. Accounts from early public health observers, including members of the Russian Red Cross mission in the late 19th century, identified malaria as a major burden even then. By the mid-20th century, the scale of the crisis had prompted an ambitious eradication campaign. In 1959, the Ethiopian government, with international support, set a target to eliminate malaria by 1980, following estimates of one million cases and 50,000 deaths annually.
That goal was never realized.
Malaria transmission in Ethiopia is characterized as unstable — fluctuating with seasonal and climatic variations rather than persisting uniformly throughout the year. Transmission typically peaks twice annually, following the rainy seasons, in the months of October and November and again in May and June. These patterns, coupled with periodic epidemics that recur every five to seven years, have made sustained control difficult.
The disease itself is caused by Plasmodium parasites transmitted through the bites of infected female Anopheles mosquitoes. While the biology is well understood and the tools for prevention and treatment are widely available, the epidemiology remains complex, shaped by environmental conditions, population movement and gaps in health system coverage.
To its credit, Ethiopia has made measurable progress. Over the past two decades, the country has reduced malaria incidence, morbidity and mortality by more than half. Yet recent trends are troubling. Between 2021 and 2022, reported cases rose by 23 percent, from 1.5 million to 1.8 million — a reversal attributed largely to the disruptions caused by the Covid-19 pandemic and armed conflict.
Despite global declines in malaria, the disease continues to rank among the leading causes of illness in Ethiopia, particularly for children. Periodic outbreaks still leave hundreds of thousands ill, placing heavy strain on already limited resources. The country ranks among the top recipients of malaria funding in Africa, yet the returns on these investments remain uneven.
Decades of interventions — from insecticide-treated bed nets to indoor residual spraying and expanded diagnostic and treatment services — have not eliminated the disease. Ethiopia has built substantial institutional capacity, supported by national programs, international partnerships and sustained financial investment. And yet malaria persists as one of the country’s most entrenched health burdens.
This paradox is difficult to ignore: malaria is both preventable and curable, and still, it endures.
Why, then, has Ethiopia failed to break the cycle of malaria?
The answer lies in a convergence of forces — environmental, biological and systemic — that continue to undermine even the most sustained control efforts.
Climate change is among the most consequential. Rising temperatures and shifting rainfall patterns are expanding the ecological range of malaria-carrying mosquitoes, enabling them to survive and reproduce in areas that were once inhospitable. In Ethiopia, this is compounded by recurring climate shocks, including El Niño events, which alter transmission dynamics and periodically intensify outbreaks.
Geography further complicates the picture. Much of Ethiopia’s landscape — particularly its lowland and semi-lowland regions — provides ideal breeding conditions for Anopheles mosquitoes. But the boundaries are no longer fixed. In recent years, malaria transmission has been reported in highland areas previously considered low-risk, including parts of Addis Ababa. This upward spread signals a troubling shift, one that could expose millions more to infection.
The biology of the disease itself adds another layer of difficulty. Plasmodium falciparum, the most severe and deadly form of malaria, accounts for roughly 70 percent of cases in Ethiopia, followed by Plasmodium vivax. These parasites are not static; they evolve, adapt and, in some cases, develop resistance to treatment. At the same time, the mosquito vectors are also changing. The emergence of Anopheles stephensi — now identified in eastern Ethiopia — poses a new and significant threat. The WHO has warned that its spread could complicate malaria control efforts across Africa, particularly because it thrives in urban environments.
Human vulnerability remains uneven and deeply entrenched. Children under five, pregnant women, the elderly and mobile populations such as seasonal workers face the highest risks. Recent evidence suggests that infection rates are rising among children aged one to four — a particularly alarming trend given the disease’s severity in this group. The consequences extend beyond immediate illness: repeated infections contribute to long-term health complications, while mortality in early childhood carries profound social and economic costs.
Beyond biology and climate, systemic gaps continue to sustain transmission. In many communities, awareness of prevention and early treatment remains limited. Access to care is uneven, particularly in rural areas where the burden is highest. Diagnostic challenges — including the sensitivity and reliability of rapid test kits — can delay or obscure detection, while asymptomatic infections allow the parasite to circulate silently within populations.
Preventive tools are available but inconsistently used. Insecticide-treated bed nets and indoor spraying programs have demonstrated effectiveness, yet coverage and proper utilization remain uneven. In some cases, bed nets are repurposed for non-medical uses, reflecting both economic pressures and gaps in public health education.
Taken together, these factors form a reinforcing cycle: environmental change expands risk, biological adaptation sustains transmission, and systemic limitations hinder response. Breaking that cycle will require more than incremental improvements.
At its core, the persistence of malaria in Ethiopia reflects deeper structural realities. The disease thrives where poverty endures — in conditions defined by low income, malnutrition, inadequate water supply and poor sanitation. Open defecation, stagnant water and unprotected water sources create ideal breeding environments for mosquitoes, reinforcing a cycle in which exposure is constant and prevention remains fragile.
Medical tools alone cannot offset these conditions.
Vaccination offers a promising addition to the malaria response, with emerging evidence showing meaningful reductions in severe disease among children. Yet its impact depends on equitable access and integration into broader public health strategies.
At the same time, the efficacy of existing treatments is under growing threat. Antimicrobial resistance — driven by the irrational prescription, dispensing and use of antimalarial drugs — is an escalating concern. While treatment success rates in Ethiopia remain relatively high, with studies indicating efficacy above 90 percent for Plasmodium falciparum, early signs of treatment failure are evident. The World Health Organization has already raised concerns about suspected artemisinin resistance in the region. If left unchecked, this could erode one of the most effective lines of defense against the disease.
The challenge is compounded by constraints in financing. Malaria control, long one of the most heavily funded areas of global health, is increasingly vulnerable to shifting political priorities and funding cuts. Reductions in international support — including cuts tied to decisions by major donor governments — threaten to disrupt both ongoing programs and future interventions. In a system already under strain, such volatility carries serious consequences.
What emerges is a picture of complexity: a disease shaped not only by parasites and vectors, but by economics, governance and human behavior. Molecular and genomic factors — including parasite mutation and vector resistance — further complicate control efforts, requiring more sophisticated surveillance and response systems.
The path forward demands a recalibration.
Improving living conditions must be central, not peripheral, to malaria control. Investments in water, sanitation and housing are as critical as bed nets and medicines. Climate adaptation strategies must be integrated into health planning. Surveillance systems — including real-time data, genomic tracking and predictive modeling — should be strengthened and scaled nationally to anticipate outbreaks rather than merely respond to them.
Interventions must also become more targeted. High-risk populations — children, pregnant women and communities in transmission hotspots — require tailored strategies. Emerging threats, such as invasive mosquito species and drug resistance, must be addressed with urgency and scientific rigor.
Equally important is public engagement. Community awareness, early care-seeking behavior and proper use of preventive and treatment tools remain decisive factors. Simple measures — draining standing water, consistent use of bed nets, completing prescribed treatments — can significantly reduce transmission when widely adopted.
Malaria control, in other words, is not solely the responsibility of health institutions. It is a collective endeavor.
Ethiopia has the technical knowledge, institutional foundation and historical experience to confront the disease. What remains is the alignment of resources, policy and public action to match the scale and persistence of the challenge.
The stakes are immediate. The coming transmission seasons — particularly the peak months of May and June — will test the country’s preparedness once again.
Without a shift from reactive cycles to anticipatory strategy, malaria will continue to return — not as an inevitability, but as a failure to act on what is already known.
Bedilu Abebe is a public health Specialist, lecturer and researcher. He is a PhD Candidate at Jimma univesity and can be reached via [email protected]
Contributed by Bedilu Abebe
